SCHEMBL22064059

SCHEMBL22064059

NC(=O)CCCSS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14682705 0.86
SCHEMBL94566 0.78
SCHEMBL3068716 0.77 TSHR (0.44)
SCHEMBL3078846 0.77 TSHR (0.45)
SCHEMBL2205401 0.74
SCHEMBL170631 0.72
SCHEMBL5067235 0.72 TSHR (0.48)
SCHEMBL21541203 0.72
SCHEMBL125606 0.71 KMT2A (0.48)
SCHEMBL984694 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3210627-B1 CONJUGATES OF CELL BINDING MOLECULES WITH CYTOTOXIC AGENTS HANGZHOU DAC BIOTECH CO LTD (CN) 2022-12-21 EP disclosed
EP-3558391-B1 IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF IMMUNOGEN INC (US) 2022-02-02 EP disclosed
EP-3842459-A1 ANTI-CD123 ANTIBODIES AND CONJUGATES AND DERIVATIVES THEREOF ImmunoGen, Inc. (US) 2021-06-30 EP disclosed
EP-3313884-B9 ANTI-CD123 ANTIBODIES AND CONJUGATES AND DERIVATIVES THEREOF IMMUNOGEN INC (US) 2021-05-19 EP disclosed
EP-3313884-B1 ANTI-CD123 ANTIBODIES AND CONJUGATES AND DERIVATIVES THEREOF IMMUNOGEN INC (US) 2020-11-18 EP disclosed
EP-3189056-B1 CYTOTOXIC BENZODIAZEPINE DERIVATIVES IMMUNOGEN INC (US) 2020-06-10 EP disclosed